These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 32606957)

  • 1. Synergistic Anticancer Effects of Gemcitabine with Pitavastatin on Pancreatic Cancer Cell Line MIA PaCa-2 in vitro and in vivo.
    Chen YH; Chen YC; Lin CC; Hsieh YP; Hsu CS; Hsieh MC
    Cancer Manag Res; 2020; 12():4645-4665. PubMed ID: 32606957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment with gemcitabine and TRA-8 anti-death receptor-5 mAb reduces pancreatic adenocarcinoma cell viability in vitro and growth in vivo.
    DeRosier LC; Huang ZQ; Sellers JC; Buchsbaum DJ; Vickers SM
    J Gastrointest Surg; 2006 Nov; 10(9):1291-300; discussion 1300. PubMed ID: 17114015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heptadecanoic Acid, an Odd-Chain Fatty Acid, Induces Apoptosis and Enhances Gemcitabine Chemosensitivity in Pancreatic Cancer Cells.
    Kim HY; Moon JY; Cho SK
    J Med Food; 2023 Mar; 26(3):201-210. PubMed ID: 36716276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced Anti-tumor Effect of Flavopiridol in Combination With Gemcitabine in Pancreatic Cancer.
    Chung KH; Cho IR; Paik WH; Kim YT; Lee SH; Ryu JK
    Anticancer Res; 2024 Mar; 44(3):1097-1108. PubMed ID: 38423644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biodegradable nanocarrier of gemcitabine and tocopherol succinate synergistically ameliorates anti-proliferative response in MIA PaCa-2 cells.
    Behera C; Kaur Sandha K; Banjare N; Kumar Shukla M; Mudassir Ali S; Singh M; Gupta PN
    Int J Pharm; 2024 Jan; 649():123599. PubMed ID: 37992978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pitavastatin and metformin synergistically activate apoptosis and autophagy in pancreatic cancer cells.
    Chen YH; Huang YC; Yang SF; Yen HH; Tsai HD; Hsieh MC; Hsiao YH
    Environ Toxicol; 2021 Aug; 36(8):1491-1503. PubMed ID: 33886150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a combination of S-1 and gemcitabine on cell cycle regulation in pancreatic cancer cell lines.
    Morimoto Y; Takeuchi O; Takizawa A; Yoneyama H; Asanuma F; Suzuki Y; Atsuda K; Yamada Y
    Anticancer Drugs; 2012 Jun; 23(5):505-14. PubMed ID: 22334000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular Cytidine Deaminase Regulates Gemcitabine Metabolism in Pancreatic Cancer Cell Lines.
    Bjånes TK; Jordheim LP; Schjøtt J; Kamceva T; Cros-Perrial E; Langer A; Ruiz de Garibay G; Kotopoulis S; McCormack E; Riedel B
    Drug Metab Dispos; 2020 Mar; 48(3):153-158. PubMed ID: 31871136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of lorglumide on growth and invasion of human pancreatic cancer cell line Mia PaCa-2 in vitro through the cholecystokinin-cholecystokinin-1 receptor pathway.
    Zhou J; Zhang ZX; Li DC
    Curr Ther Res Clin Exp; 2010 Aug; 71(4):239-51. PubMed ID: 24688146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aldehyde dehydrogenase 1A1 confers intrinsic and acquired resistance to gemcitabine in human pancreatic adenocarcinoma MIA PaCa-2 cells.
    Duong HQ; Hwang JS; Kim HJ; Kang HJ; Seong YS; Bae I
    Int J Oncol; 2012 Sep; 41(3):855-61. PubMed ID: 22710732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of Hematopoietic Pre-B-cell Leukemia Transcription Factor Interacting Protein Knockdown on Proliferation,Cell Cycle and Apoptosis in Pancreatic Cancer Cells].
    Zhao YM; Yang G; You L; Hu Y; Zhao YP
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2020 Feb; 42(1):7-15. PubMed ID: 32131934
    [No Abstract]   [Full Text] [Related]  

  • 12. Nicotine promotes epithelial to mesenchymal transition and gemcitabine resistance via hENT1/RRM1 signalling in pancreatic cancer and chemosensitizing effects of Embelin-a naturally occurring benzoquinone.
    Prashanth N ; Meghana P ; Sandeep Kumar Jain R ; Pooja S Rajaput ; Satyanarayan N D ; Raja Naika H ; Kumaraswamy H M
    Sci Total Environ; 2024 Mar; 914():169727. PubMed ID: 38163613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticancer effects of phenoxazine derivatives combined with tumor necrosis factor-related apoptosis-inducing ligand on pancreatic cancer cell lines, KLM-1 and MIA-PaCa-2.
    Kato S; Shirato K; Imaizumi K; Toyota H; Mizuguchi J; Odawara M; Che XF; Akiyama S; Abe A; Tomoda A
    Oncol Rep; 2006 Apr; 15(4):843-8. PubMed ID: 16525669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The flavonoid p-hydroxycinnamic acid exhibits anticancer effects in human pancreatic cancer MIA PaCa-2 cells in vitro: Comparison with gemcitabine.
    Yamaguchi M; Murata T; El-Rayes BF; Shoji M
    Oncol Rep; 2015 Dec; 34(6):3304-10. PubMed ID: 26397991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CNT1 expression influences proliferation and chemosensitivity in drug-resistant pancreatic cancer cells.
    Bhutia YD; Hung SW; Patel B; Lovin D; Govindarajan R
    Cancer Res; 2011 Mar; 71(5):1825-35. PubMed ID: 21343396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination effects of amino acid transporter LAT1 inhibitor nanvuranlat and cytotoxic anticancer drug gemcitabine on pancreatic and biliary tract cancer cells.
    Nishikubo K; Ohgaki R; Liu X; Okanishi H; Xu M; Endou H; Kanai Y
    Cancer Cell Int; 2023 Jun; 23(1):116. PubMed ID: 37322479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of HMJ-38, a new quinazolinone analogue, against the gemcitabine-resistant MIA-PaCa-2 pancreatic cancer cells.
    Hour MJ; Tsai FJ; Lai IL; Tsao JW; Chiang JH; Chiu YJ; Lu HF; Juan YN; Yang JS; Tsai SC
    Biomedicine (Taipei); 2023; 13(4):20-31. PubMed ID: 38532833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [MiR-150-5p inhibits the proliferation and promoted apoptosis of pancreatic cancer cells].
    Sun Y; Jin XL; Zhang TT; Jia CW; Chen J
    Zhonghua Bing Li Xue Za Zhi; 2013 Jul; 42(7):460-4. PubMed ID: 24246865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gatifloxacin induces S and G2-phase cell cycle arrest in pancreatic cancer cells via p21/p27/p53.
    Yadav V; Sultana S; Yadav J; Saini N
    PLoS One; 2012; 7(10):e47796. PubMed ID: 23133524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined pitavastatin and dacarbazine treatment activates apoptosis and autophagy resulting in synergistic cytotoxicity in melanoma cells.
    Al-Qatati A; Aliwaini S
    Oncol Lett; 2017 Dec; 14(6):7993-7999. PubMed ID: 29344241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.